Figure 2.
Recommendation for evaluation of protein binding in the clinical development. The role of PPB on efficacy models needs to be rigorously evaluated and established throughout the preclinical and clinical development stages as suggested and outlined by this general scheme. PPB: plasma protein binding; NTI: narrow therapeutic index.3 Reproduced with permission from [3].